IMPORTANT: Beginning at 8:00 AM on September 3, Temple University Hospital – Main Campus (Broad and Ontario Streets) will no longer provide Labor and Delivery services. All childbirth services will be relocated to our new hospital location.

SEARCH TEMPLE HEALTH
Transplant Program

Kidney Transplant Symposium 2025: Navigating Through Transplant

Event Details

October 28, 2025

Marriott Philadelphia West
111 Crawford Ave
Conshohocken, PA 19428

At this year's in-person Kidney Transplant Symposium, attendees will learn about the continuum of care for patients who require a kidney transplant with an emphasis on:

  • Optimizing clinical management
  • Patient education and support before and after kidney transplantation

The symposium will include presentations by members of the Temple Kidney Transplant Program and personal accounts from living donors and recipients.

Objectives

Antonio di Carlo, MD, CM, FACS, FRCSC  
Professor, Surgery, Lewis Katz School of Medicine at Temple University 
Chief, Abdominal Organ Transplant Surgery, Lewis Katz School of Medicine at     Temple University 

Kenneth Chavin, MD, MBA, PhD FACS 
Professor, Surgery, Lewis Katz School of Medicine at Temple University 
Director, Abdominal Organ Transplant Program, Temple University Hospital 

Objectives: 

  • Review Transplant options: Type I dm and type II dm Simultaneous pancreas and kidney
  • Discuss Living kidney donation
  • Discuss Aggressive decease donor kidney transplant
  • Define transplant for patients with renal failure

Kristin E. Criner, MD: Safety and efficacy of GLP-1 agonists in Post-transplant Diabetes 
Associate Professor, Clinical Medicine, Lewis Katz School of Medicine at Temple     University and Endocrinologist 

Objectives: 

  •  Understand the pathophysiology of post-transplant diabetes
  • Evaluate studies using GLP-1 agonists in the transplant population for diabetes
  • Review the safety of GLP-1 agonists in this patient population. Renal Genetics and Society Guidelines 

Ronen Schneider, MD: Renal Genetics and Society Guidelines 
Medical Director of Renal Genetics in the Division of Organ Health at Natera 

Objectives:  

  • Review literature to understand the prevalence of heritable forms of CKD
  •  Explore recent society statements and guidelines on patient identification and testing strategy for genetic forms of CKD
  •  Understand direct and indirect patient implications for identifying a genetic etiology for CKD, such as changes in treatment, kidney transplant considerations, prognostication, and impacts on family members.

Velma Scantlebury, MD, FACS, GCM: Racial Disparities in Kidney Transplant 
Chief Medical Officer at the Delaware Health Equity Coalition 
Adjunct Professor of Surgery at the Giesel School of Medicine at Dartmouth College and Co-Leader for the Race and Health Equity (RHE) Curriculum 

Objectives 

  • Understand what ethnic and racial disparities are
  • Describe how racism plays a role in contributing to the inequities in healthcare and transplantation
  • List three social determinants of health factors that play a role keeping patients from getting on the waitlist
  • Understand the medical, systemic and cultural factors that can negatively influence living donation 

Joe Paparo: Gift of Life Donor Program – Collaborating for Life: An Overview of the Organ and Tissue Donation Process 
Senior Hospital Services Coordinator, Gift of Life Donor Program 

Objectives:  

  • Describe the Process in which a Patient is Referred for Possible Organ Donation in the Hospital Setting
  • Differentiate Between the Brain Death and Donation After Circulatory Death (DCD) Donation Pathways
  • Explain the Basics of How Organs are Allocated for Transplant
  • Clarify for their Patients which Donated Gifts they may Meet Criteria to Donate 

Dr. Christopher Combs, PhD: Substance Abuse and Mental Health 
Associate Professor of Clinical Psychiatry and Behavioral Science at the Lewis Katz     School of Medicine at Temple University 

Objectives:  

  • Define the types of substance abuse (e.g., alcohol, opioids, stimulants, cannabis) commonly encountered in kidney transplant populations.
  • Describe the impact of active or past substance abuse on transplant candidacy and graft outcomes.
  • Review current guidelines and institutional practices for screening and evaluating substance use in transplant candidates.
  • Identify evidence-based treatment and harm-reduction strategies tailored to patients with substance-use disorders pre- and post-transplant.
  • Discuss ethical and policy considerations in transplant listing decisions for patients with a history of substance abuse.
  • Recognize the importance of interdisciplinary collaboration in managing these patients. 

Ryan Ihlenfeldt, DNP, RN, CCRN: Living Kidney Donation 
Director, Clinical Transplant Services of Abdominal Organ Transplant at Temple     University Hospital 

Objectives:  

  • Understand the foundation and impact of living kidney donation
  • Describe the benefits of living donor kidney transplant
  • Recognize the living donation team and the evaluation process
  • Discuss future advances in living donation matching
  • Demonstrate how you can assist patients with finding living donors 

Diana R. Kline: Overcoming Barriers to Transplant 
Transplant Outreach Education Coordinator for Abdominal Organ Transplant at     Temple University Hospital 

Objectives: 

  • Describe the scope of practice and essential contributions of the panel members
  • Identify key barriers/propose strategies to overcome through collaborative team efforts
  • Recognize early indicators of transplant readiness
  • Evaluate case scenarios discussed by panelists
  • Summarize and interpret recent updates to transplant eligibility criteria and allocation policies 

Diana R. Kline: Voices of Living Donation 
Transplant Outreach Education Coordinator for Abdominal Organ Transplant at Temple University Hospital

Objectives: 

  • Describe the lived experience of both a transplant recipient and a living donor
  • Recognize opportunities to provide support throughout the transplant and donation process
  • Evaluate how personal narratives can inform ethical, culturally competent decision-making and education practices in clinical settings
  • Identify ways social workers can advocate for patients and families during the transplant referral, evaluation, and recovery phases 

Thank you to the Kidney Transplant Symposium 2025 Sponsors:

Presenting Sponsors

Presenting Sponsors

Symposium Champions

Symposium Advocates

Symposium Advocates

Symposium Supporters

  • Biomatrix
  • Heartbeat Perfusions
  • Eurofins
  • Dialysis Clinic, Inc (DCI)